Medimmune Limited

Tord Inghardt

Philip Newton

Feenagh Keyes

Mark Penney

Sven Nylander

Andrew Grier Buchanan

Andrew Buchanan

The disclosure generally provides antibodies and antigen binding fragments of antibodies that bind ticagrelor and metabolites of ticagrelor. The disclosure also provides compositions comprising the antibodies, nucleic acid molecules encoding the antibodies, methods of treating a patient comprising administering the antibodies, and methods of making and using the antibodies.

Growing community of inventors

Sodertalje, Sweden

Tord Inghardt